Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Researchers have created a slow-release ‘smart’ insulin that responds to blood glucose levels to provide week-long control with virtually no incidents of low blood sugar. Tested in mice and minipigs, ...

First randomized controlled trial to evaluate direct transition from multiple daily injections to automated insulin delivery in adults and children with type 1 diabetes who were not meeting glycemic ...

Please provide your email address to receive an email when new articles are posted on . Patients receiving injections of autologous adipose-derived stem cells or adipose-derived stromal vascular ...

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio. At some point next month, a handful of volunteers will be injected with two ...

Background: Severe hypoglycaemia (SH) is one of the most feared complications of type 1 diabetes (T1DM) with a reported prevalence of nearly 40%. In randomized trials of Multiple Daily Injections (MDI ...